Access BayerPRO

<p>Stay up to date with exclusive content for Healthcare Professionals:</p><ul><li>Latest updates</li><li>Find useful tools for your practice</li><li>Access patient support materials</li></ul>

Sign up to BayerMED:

Register | Login For Further Access

404 Page

Default

You Are About To Leave The Current Site

Training

Training Title

Learning Materials

Medical Literature 

Chronic Kidney Disease 

Awareness​

Menopause

Clinical Tools 

Contraception

Women's Health

Medical Literature

Prostate Cancer

Heart Failure 

Oncology

Cardio Renal 

Ophthalmology

Bayer Logo

Womens Health.png

Plain Blue Hero Banner.png

Other

small_Cardiovascular_32px.png

Heart Failure

small_Ophthalmology_32px.png

Oncologie

Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial

media:remote_media:cbd4dcca-74fc-45e3-92b2-dd83f3075a51

Radium-223 in combination with therapies for metastatic castration-resistant prostate cancer: an international phase 3b trial

Ask a Question